Alan L Epstein

USPTO Granted Patents = 33 (Patent Applications = 12)

CIPO Patents = 2 (Patent Applications = 7)

EPO Patents = 4 (Patent Applications = 10)

Average Co-Inventor Count = 2.0

ph-index = 13

Forward Citations = 623(Granted Patents)

Location History:

La Canada, CA (US) (1988 - 2021)
Pasadena, CA (US) (2014 - 2021)
Los Angeles, CA (US) (2023)

Company Filing History:

24 out of 1,628

University of Southern California

Cancer Biologics, Inc.

patents

4. 2 out of 2,117

Northwestern University

patents

Years Active: 1988-2023

Loading Chart...

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11667715 - Lym-1 and Lym-2 antibody compositions and improved car constructs (2023-06-06),

2. 11136401 - Car t-cell therapy directed to LHR for the treatment of solid tumors (2021-10-05),

3. 10961317 - CD20 scFv-ELPs methods and therapeutics (2021-03-30),

4. 10711064 - Lym-1 and Lym-2 targeted CAR cell immunotherapy (2020-07-14),

5. 10196435 - OX40L fusion protein for the immunotherapy of tumors of veterinary animals (2019-02-05),

6. 9746480 - Human myeloid derived suppressor cell cancer markers (2017-08-29),

7. 9522958 - Cancer targeted innate immunity (2016-12-20),

8. 8883497 - Human myeloid derived suppressor cell cancer markers (2014-11-11),

9. 8795672 - Compositions and methods for cancer immunotherapy (2014-08-05),

10. 8545838 - Compositions and methods for cancer immunotherapy (2013-10-01),

11. 8268788 - Combination cancer immunotherapy with co-stimulatory molecules (2012-09-18),

12. 8207130 - Combination cancer immunotherapy with co-stimulatory molecules (2012-06-26),

13. 8124066 - Methods of using interleukin-2 mutants with reduced toxicity (2012-02-28),

14. 7803361 - Therapeutic use of interleukin-2 mutants (2010-09-28),

15. 7696175 - Combination cancer immunotherapy with co-stimulatory molecules (2010-04-13),

Title: Alan L Epstein: A Trailblazer in Innovation

Introduction: Alan L Epstein, a visionary inventor based in La Canada, CA, has established a remarkable legacy in the realm of technological advancements. With a portfolio boasting 33 patents and a relentless pursuit of innovation, Epstein has inspired countless future inventors to push boundaries and think creatively.

Latest Patents: Among Epstein's latest patents are the groundbreaking Lym-1 and Lym-2 antibody compositions and improved car constructs. These patents introduce novel antibodies and chimeric antigen receptor (CAR) cells designed for detecting and treating cancer, particularly in solid tumors like ovarian and prostate cancer. His work showcases a deep commitment to revolutionize cancer treatment through cutting-edge technology.

Career Highlights: Alan L Epstein has made significant contributions during his tenure at renowned institutions such as the University of Southern California and Techniclone, Inc. His innovative spirit and dedication to technological advancement have earned him a prominent place in the field of inventors, with each patent reflecting his unwavering commitment to progress.

Collaborations: Throughout his career, Epstein has collaborated with esteemed colleagues like Peisheng Hu and Leslie A Khawli. These relationships have been instrumental in translating his inventive ideas into tangible solutions, further solidifying his reputation as a collaborative and forward-thinking inventor.

Conclusion: Alan L Epstein's impact on the technological landscape is undeniable, with his patents and inventions serving as a testament to his ingenuity and dedication to innovation. His legacy will continue to inspire generations of inventors to push boundaries, dream big, and make a lasting mark on the world of technology.

This text is generated by artificial intelligence and may not be accurate.